SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001919
Filing Date
2023-08-14
Accepted
2023-08-14 17:00:40
Documents
54
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snpx-20230630x10q.htm   iXBRL 10-Q 1640211
2 EX-31.1 snpx-20230630xex31d1.htm EX-31.1 9377
3 EX-31.2 snpx-20230630xex31d2.htm EX-31.2 11840
4 EX-32.1 snpx-20230630xex32d1.htm EX-32.1 7527
5 EX-32.2 snpx-20230630xex32d2.htm EX-32.2 6777
  Complete submission text file 0001410578-23-001919.txt   6453527

Data Files

Seq Description Document Type Size
6 EX-101.SCH snpx-20230630.xsd EX-101.SCH 57212
7 EX-101.CAL snpx-20230630_cal.xml EX-101.CAL 27705
8 EX-101.DEF snpx-20230630_def.xml EX-101.DEF 221566
9 EX-101.LAB snpx-20230630_lab.xml EX-101.LAB 435617
10 EX-101.PRE snpx-20230630_pre.xml EX-101.PRE 352118
48 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20230630x10q_htm.xml XML 816273
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 231171719
SIC: 2834 Pharmaceutical Preparations